KAREN VALENTINE
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
GARO ARMEN, GARO H ARMEN, GARO H. ARMEN, CHARLES EVAN BALLANTYNE, OZER BAYSAL, JENNIFER BUELL, CHRISTIAN CORTIS, BRIAN CORVESE, TOM DECHAENE, ALEX DUNCAN, JOHN HATSOPOULOS, ALLISON JEYNES-ELLIS, WADIH JORDAN, EVAN KEARNS, CHRISTINE KLASKIN, CHRISTINE M KLASKIN, CHRISTINE M. KLASKIN, HYAM I LEVITSKY, M. D., HYAM I LEVITSKY, M.D, SHAHZAD MALIK, TIMOTHY ROTHWELL, SHALINI SHARP, ROBERT STEIN, ROBERT B. STEIN, KAREN H. VALENTINE, KERRY WENTWORTH, KERRY A WENTWORTH, ULF WIINBERG, TIMOTHY WRIGHT, TIMOTHY R. WRIGHT
EXECUTIVE OFFICER
GARO ARMEN, GARO H ARMEN, GARO H. ARMEN, CHARLES EVAN BALLANTYNE, OZER BAYSAL, JENNIFER BUELL, CHRISTIAN CORTIS, BRIAN CORVESE, TOM DECHAENE, ALEX DUNCAN, JOHN HATSOPOULOS, ALLISON JEYNES-ELLIS, WADIH JORDAN, EVAN KEARNS, CHRISTINE KLASKIN, CHRISTINE M KLASKIN, CHRISTINE M. KLASKIN, HYAM I LEVITSKY, M. D., HYAM I LEVITSKY, M.D, SHAHZAD MALIK, TIMOTHY ROTHWELL, SHALINI SHARP, ROBERT STEIN, ROBERT B. STEIN, KAREN H. VALENTINE, KERRY WENTWORTH, KERRY A WENTWORTH, ULF WIINBERG, TIMOTHY WRIGHT, TIMOTHY R. WRIGHT
EXECUTIVE OFFICER
JAMES E. AUDIA, GAREN BOHLIN, SCOTT BRAUNSTEIN, MICHAEL R. COOPER, KEITH DIONNE, ANTHONY EVNIN, DAVID GOEDDEL, MARK A. GOLDSMITH, EDWARD E. HARLOW, JR., STEVEN HOERTER, MATTHIAS JAFFE, MARK LEVIN, TOM MANIATIS, STEVEN PAUL, JIGAR RAYTHATHA, EMMA REEVE, KERRY K. REINERTSEN, ADRIAN SENDEROWICZ, PETER SVENNILSON, ROBERT TEPPER, ELIZABETH G. TREHU, PATRICK TROJER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-10-01
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2015-02-18
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Debt
2015-02-20
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Debt
2013-04-15
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2009-08-03
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2009-08-04

